Ivermectin (IVE), one of the most important anthelmintics, is often used in the treatment of haemonchosis in ruminants. The objective of our work was (1) to find and identify phase I and II metabolites of IVE formed by the Barber's pole worm (Haemonchus contortus), and (2) to compare IVE metabolites in helminths with IVE biotransformation in sheep (Ovis aries) as host species. Ultrahigh-performance liquid chromatography/tandem mass spectrometry (UHPLC/MS/MS) was used for this purpose. During in vitro incubations, microsomes (from adult worms or from ovine liver) and a primary culture of ovine hepatocytes were incubated with IVE. In the ex vivo study, living H. contortus adults were incubated in the presence of 1 μM IVE for 24 h. The results showed that the H. contortus enzymatic system is not able to metabolize IVE. On the other hand, 7 different phase I as well as 9 phase II IVE metabolites were detected in ovine samples using UHPLC/MS/MS analyses. Most of these metabolites have not been described before. Haemonchus contortus is not able to deactivate IVE through biotransformation; therefore, biotransformation does not contribute to the development of IVE-resistance in the Barber's pole worm.
I N T R O D U C T I O N
The Barber's pole worm (Haemonchus contortus) is a very common gastrointestinal nematode and one of the most pathogenic parasites of ruminants (e.g., sheep and goats). The control of haemonchosis has been and still is based on the use of anthelmintics. The infection is usually treated with broad-spectrum anthelmintics, such as benzimidazoles, macrocyclic lactones and salicylanilides (Getachew et al. 2007 ). However, the widespread and indiscriminate use of these treatments has led to the emergence of parasitic isolates with anthelmintic resistance to the main antiparasitic drug groups. Several patterns of drug resistance have been described in helminths (i.e., Wolstenholme et al. 2004; James et al. 2009) . One of these is associated with biotransformation enzymes that are responsible in some cases for the faster deactivation of anthelmintics in resistant parasites (Robinson et al. 2004; Alvarez et al. 2005; Devine et al. 2010a,b) .
The biotransformation of benzimidazole anthelminthics has been studied and proven in several helminths, including Haemonchus contortus, with significant inter-species differences being observed (Solana et al. 2001; Mottier et al. 2004; Robinson et al. 2004; Alvarez et al. 2005; Cvilink et al. 2008a Cvilink et al. , b, 2009a . On the other hand, H. contortus was neither in vitro nor ex vivo able to metabolize the salicylanilide anthelmintic closantel (Rothwell and Sangster, 1997) . The macrocyclic lactones (avermectins and milbemycins) are products (or chemical derivatives thereof) of soil microorganisms belonging to the genus Streptomyces. Alvinerie et al. (2001) have reported the formation of one metabolite of moxidectin in H. contortus homogenate incubations. The metabolic pathway of ivermectin (IVE) has been studied in mammals, with members of the cytochrome P450 superfamily identified as the principal metabolizing enzymes (Miwa et al. 1982; Chiu et al. 1984; Zeng et al. 1998) . No information about IVE biotransformation in helminths has been made available so far.
The goal of the present work is to determine whether or not H. contortus is able to metabolize IVE. The metabolites of phase I and phase II IVE biotransformation formed by H. contortus were searched for in vitro as well as ex vivo. IVE biotransformation was also tested in sheep to compare the IVE metabolites formed in helminths with those formed in their hosts.
M A T E R I A L S A N D M E T H O D S

Chemicals
Ivermectin H 2 B 1a was purchased from SigmaAldrich (St Louis, MO, USA). Acetonitrile (LC/MS grade) and ammonium acetate were purchased from Sigma-Aldrich (St Louis, MO, USA). De-ionized water was prepared with the Demiwa 5-roi purification system (Watek, Ledeč nad Sázavou, Czech Republic). Liquid sterile-filtered RPMI-1640 medium, HAM F12 medium, Williams' E medium, foetal calf serum and all other chemicals (LC/MS, HPLC or analytical grade) were obtained from Sigma-Aldrich (Prague, Czech Republic).
Collection of parasite material
The susceptible isolate of Haemonchus contortus has been used in this study. The H. contortus ISE strain is an anthelminthic-susceptible inbred type of the SE strain (Roos et al. 2004) , which had been isolated from the field before benzimidazole anthelmintics were introduced to the market. Four parasite-free lambs (3-4 months old) were orally infected with 5000 L3 larvae of H. contortus. Seven weeks after infection the animals were stunned and immediately exsanguinated in agreement with Czech slaughtering rules for farm animals. Adult nematodes were removed from sheep abomasum using the agar method described by Van Wyk et al. (1980) . The isolated parasites were either used immediately for ex vivo experiments or frozen at −80°C for preparation of subcellular fractions for in vitro studies.
Preparation of microsomes and incubation with ivermectin (IVE)
Microsomes from homogenates of H. contortus adults were prepared as described previously (Cvilink et al. 2008a) . Microsomes from the ovine liver were prepared by the same procedure. All microsomal fractions were stored at −80°C. No other subcellular fractions (cytosolic or mitochondrial) were used for incubations with IVE. Protein concentrations were assayed using the bicinchoninic acid method according to the Sigma protocol.
The reaction mixture (total volume of 0·3 ml) contained 100 μl of microsomes (approximately 0·4 mg of proteins), 100 μM IVE pre-dissolved in dimethyl sulfoxide (concentration of DMSO in the reaction mixture was 1%), 1 mM NADPH and 0·1 M sodium phosphate buffer (pH 7.4). Blank samples contained 100 μl of 0·1 M sodium phosphate buffer instead of microsomes or 1% DMSO instead of IVE. All incubations were carried out at 37°C for 30 min.
At the end of the incubation, 30 μl of ammonium hydroxide solution (25% v/v) and 700 μl of ethyl acetate were added. After shaking (3 min, vortex) and centrifugation (3 min, 5000 g) of the mixture, the supernatants were removed and subsequently evaporated to dryness using vacuum concentrator. Samples were stored at −80°C until LC/MS analysis.
Ex vivo experiment
Living nematodes were cultivated as described by Kotze and McClure (2001) with a modification according to Cvilink et al. (2008b) . At the beginning of incubation, 2·5 ml of medium was removed from each flask with nematodes and the same volume of fresh medium with IVE was added. IVE was predissolved in DMSO; the final concentration of DMSO in medium was 0·1%. Nematodes were incubated in medium with 1 μM IVE for 24 h. In chemical blank samples, medium was incubated with 1 μM IVE but without nematodes. In biological blank samples, nematodes were incubated with DMSO instead of IVE. After the incubation, medium was placed into the plastic tubes. Nematodes were repeatedly washed with phosphate buffer and transferred into the plastic tubes. Samples were frozen and stored under −80°C. Prior to the analysis, parasite bodies were homogenized in redistilled water at the ratio of 1:3 (w/v) using Sonopuls (Bandelin, Germany). Medium and the parasite homogenate were then extracted using solid-phase extraction. Dried extracts were stored (− 80°C) until UHPLC/MS analyses.
Isolation of hepatocytes and incubation of hepatocytes primary culture with IVE
Ovine hepatocytes were obtained from the ovine liver by a two-step collagenase method (Berry et al. 1991; Baliharová et al. 2004) . Three million viable (80%) cells in 3 ml of culture medium ISOM (1:1 mixture of Ham F12 and Williams' E) were placed into 60 mm plastic dishes pre-coated with collagen. The fetal calf serum was added in culture medium (5%). Cultures were maintained without substrates for 4 h at 37°C in a humid atmosphere of air and 5% CO 2 . After attachment of hepatocytes, the ISOM medium was replaced with fresh serum-free medium with 10 μM IVE pre-dissolved in DMSO. The concentration of DMSO in the medium was 0·1% (v/v). Hepatocytes were incubated with IVE for 24 h at 37°C in the humid atmosphere of air and 5% CO 2 . At the end of the experiment, hepatocytes were scraped off into the incubation medium and homogenized using Sonopuls (Bandelin, Germany). Samples were then extracted using solid-phase extraction. Dried extracts were stored (− 80°C) until UHPLC/MS analyses.
Solid-phase extraction and sample preparation
Samples from ex vivo experiments and hepatocyte incubations were extracted using solid-phase extraction. Two ml of the medium, parasite or hepatocyte homogenate were centrifuged at 3000 g for 5 min. The supernatant was loaded onto a Waters Oasis HLB extraction cartridge (1cc, 30 mg, 30 μm particles; Waters) previously conditioned by washing with 1 ml of acetone, 1 ml of methanol and 1 ml of redistilled water. In the next step, the cartridge was washed with 1 ml of 5% aqueous methanol (v/v). Compounds of interest were eluted with 1 ml of methanol followed by 1 ml of acetone. Eluates were evaporated to dryness using the vacuum concentrator Eppendorf 5310 (Hamburg, Germany) and stored at −80°C until UHPLC/MS analyses.
Ultrahigh-performance liquid chromatography/tandem mass spectrometry (UHPLC/MS/MS)
Selected samples were quantitatively dissolved in 200 μl of a mixture of acetonitrile/water (1:1, v/v). UHPLC/MS/MS chromatograms of samples were measured in both positive and negative polarity modes using electrospray ionization (ESI) and hybrid quadrupole-time-of-flight (Q-TOF) Mass Analyzer microOTOF-Q (Bruker Daltonics, Bremen, Germany). UHPLC was performed on Agilent 1290 Infinity Liquid Chromatograph (Agilent Technologies, Waldbronn, Germany) using a Kinetex C18 column (150 mm × 2·1 mm, 1·7 μm, Phenomenex, Torrance, CA, USA), a temperature of 25°C, a flow rate of 0·3 ml/min and an injection volume of 1 μl. The mobile phase consisted of acetonitrile (A) and 5 mM ammonium acetate buffer with pH 6.5 (B). The linear gradient was as follows: 0 min -15% A, 15 min -95% A, 17 min -95% A; and finally washing and reconditioning of the column for 20 min. The Q-TOF mass spectrometer was used with the following setting of tuning parameters: capillary voltage 4·5 kV, drying temperature 200°C, the flow rate and pressure of nitrogen were 7 l/min and 1 bar, respectively. The external calibration was performed with sodium formate clusters before individual measurements. ESI mass spectra were recorded in the range of m/z 50-1200 both in positive-and negative-ion modes. The isolation width Δm/z 4 and the collision energy 20 eV using argon as the collision gas were used for MS/MS experiments. Advanced software tools, Metabolite Predict and Metabolite Detect (Bruker Daltonics, Bremen, Germany), were used for the data evaluation.
R E S U LT S A N D D I S C U S S I O N
In the present project the biotransformation of IVE (Fig. 1) was studied in the Barber's pole worm (Haemonchus contortus). All in vitro and ex vivo methods applied for this purpose have been used successfully in our previous studies, leading to the identification of several new metabolites of benzimidazole anthelmintics in helminths (Cvilink et al. 2008a,b) .
The analytical characterization of IVE biotransformation samples was performed using UHPLC/ MS/MS. First, full-scan and tandem mass spectra of IVE standard were measured and interpreted both in positive-ion and negative-ion modes of ESI (see Materials and Methods − were the most important ions in the negative-ion mode. Moreover, fragment ions observed mainly in positive-ion full-scan mass spectra helped to confirm the presence of IVE-related compounds. The accurate calibration of the mass scale enabled the mass accuracy, usually better than 5 ppm, to be achieved, resulting in the elemental composition determination of observed ions (Tables  1 and 2 ). In a few cases, mass accuracies were slightly worse than 5 ppm due to the very low abundances of these ions. The additional information was obtained using tandem mass spectra measurements in which typical neutral losses supported the identification of the metabolic reactions ). Reconstructed ion current chromatograms and constant neutral loss chromatograms were used for a better visualization of the UHPLC/MS/MS chromatograms. The software tools Metabolite Predict and Metabolite Detect, already described in our previous paper , were applied for the prediction of metabolites and their subsequent detection. This software was set to predict 3 generations of possible IVE metabolite structures in accordance with all metabolic rules (Holčapek et al. 2008) . The created list of particular exact m/z values was subsequently used in the process of detection of the metabolites, including the subtraction of chromatograms of placebo experiments from the chromatograms of the biotransformation samples (Fig. 2) 
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− ions of individual drug metabolites were generated.
To begin with, phase I metabolites of IVE in H. contortus were searched for in an IVE incubation of subcellular fractions of the worms. The microsome-like fraction from H. contortus was incubated with 100 μM IVE. In all samples, only ammonium adducts of the IVE molecule at m/z 892·5416 in the positive-ion mode and the deprotonated IVE molecule at m/z 873·5005 in the negative-ion mode at the retention time of 15·5 min were observed, and no phase I metabolites produced by the Barber's pole worm were detected.
Consequently, ex vivo incubations of 1 μM IVE were done with living helminths previously isolated from their hosts. Lower concentrations of IVE in the ex vivo study than in the in vitro experiments were used to avoid death of the worms and also to approximate incubation conditions to real plasmatic concentration of IVE in animals. In a medium at an IVE concentration up to 1 μM, the movement of helminths was visible during the entire incubation period and thus the helminths were alive during the whole experiment. After 24-hour incubations, medium and worm homogenates were analysed by the UHPLC/MS/MS technique and both phase I and II metabolites of IVE were searched for. In all samples, only IVE was detected without any trace of IVE metabolites.
On the other hand, when the biotransformation of benzimidazole anthelmintics was studied in H. contortus, several metabolites were found and identified in vitro as well as ex vivo (Cvilink et al. 2008a,b) . Haemonchus contortus can metabolize albendazole via sulphoxidation and glucose conjugation, and flubendazole via the reduction of a carbonyl group and subsequent glucose conjugation (Cvilink et al. 2008b) . The negative results in the detection of IVE metabolites in H. contortus necessitate additional confirmation that our analytical method was well optimized and capable of the highly sensitive detection of all possible IVE metabolites in the studied samples. For this reason, we decided to study the biotransformation of IVE in sheep in vitro at both the subcellular and cellular levels. Ovine liver microsomal fractions were incubated with 100 μM IVE, and primary cultures of ovine isolated hepatocytes were incubated with 10 μM IVE. The samples obtained were analysed using UHPLC/MS/MS. In the ovine samples, numerous IVE metabolites were detected. The phase I metabolites correspond to the IVE hydroxylation (+ O), demethylation (-CH 2 ) and the combination of both processes. The conjugation with glucuronic and sulphuric acids represented the phase II of the IVE biotransformation. In total, 7 different phase I (Table 1 ) and 9 phase II (Table 2) metabolites were identified using UHPLC/MS/MS analyses. These results clearly demonstrate the high sensitivity of our methods, resulting in the detection of new IVE metabolites in sheep not reported so far.
Previous metabolic studies of IVE performed in rats, cattle, sheep, goats, and pigs have revealed only Table 2 ). Arrows show detected metabolites (signal/noise 55).
Phase I metabolites: 24-OH-H 2 B 1a and 24-OH-H 2 B 1b in cattle, sheep, and rats (Chiu et al. 1986 ), 3″-O-desmethyl-H 2 B 1a and 3″-O-desmethyl-H 2 B 1b in pigs and goats (González Canga et al. 2009) . No phase II metabolites have been reported so far. In our experiments, 9 different phase II metabolites of IVE were found in incubations with primary cultures of ovine hepatocytes; 8 conjugates with sulphuric acid and 1 with glucuronic acid.
The present study was designed to advance our knowledge about the metabolism of IVE in helminths and their hosts. Despite the highly sensitive UHPLC/ MS/MS analyses, no IVE metabolite formed in the Barber's pole worm (H. contortus) was detected. This finding indicates that this nematode is not able to deactivate IVE through biotransformation; therefore, biotransformation does not contribute to the development of IVE-resistance in the Barber's pole worm. In sheep, the host organism of H. contortus, the UHPLC/MS/MS technique allowed us to find and identify 16 different IVE metabolites, most of which had not yet been described.
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